🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Oral NSAI Versus Acetaminophen or Placebo as a Discharge Treatment of Non Complicated Renal Colics

RecruitingPhase 2Ages 18 Years - anyAllUniversity of Monastir
NCT05722782 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Treatment with NSAI in renal colics has not been well investigated and there is no clear recommendations regarding this subject. The aim of this study is to determine if an oral NSAI treatment is beneficial in patients discharged for the emergency department after the first line treatment of a renal colic investigating the reccurence of pain, the reconsultation rates and the admissions.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Over 18 years old * Consenting to participate in the study * Patients treated in the ED for RC * No contraindications of NSAI or paracetamol treatment Exclusion Criteria: * Contraindication of NSAI treatment * Patients non reachable by telephone call * Patients that did not receive or use the treatment
💊

What it tests

  • Piroxicam
  • Acetaminophen
  • Placebo
📍

Where

1 site
Fattouma Bourguiba University Hospital
Monastir, Tunisia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy